Articles > Myeloma

  1. Announcing our New Medication Resource for Myeloma Patients

    While living with myeloma, you may have a number of different medications to take at home - medications you took prior to diagnosis, those you now take to treat myeloma, and others to reduce the side effects of treatment. The effectiveness of your medication is best when you follow your medication course as prescribed by your doctor or pharmacist. LLS is happy to share a new calendar to help you with your oral medication routine. The calendar includes helpful tips, a section for you to...

    Read More
  2. VP Biden Addresses Researchers @ ASCO16

    Speaking from the heart, Vice President Joseph Biden addressed thousands of cancer researchers today in a packed hall at the American Society of Clinical Oncology (#ASCO16) annual meeting in Chicago, to tout his Cancer Moonshot initiative. The theme of this year’s #ASCO16 meeting, “Collective Wisdom – The Future of Patient-Centered Care and Research,” is perfectly aligned with the goals of the Moonshot, Biden told the rapt audience.

    Read More
  3. Precision Medicine and Immunotherapy @ ASCO16

    The American Society of Clinical Oncology (#ASCO16) annual meeting featured several significant oral scientific presentations on the blood cancers over the weekend here in Chicago. CPX-351: A session on hematological malignancies Saturday afternoon included a discussion of final data from the Phase 3 clinical trial of Celator’s drug CPX-351 (Vyxeos ®). LLS invested substantially in this study through our Therapy Acceleration Program (TAP). The study was in a small subset of elderly pati...

    Read More
  4. Putting Patients at the Center of Care at #ASCO16

    The American Society of Clinical Oncology (#ASCO16) annual meeting kicked off today as more than 30,000 researchers from around the world converged in Chicago to share their latest clinical findings on treatments and diagnostics for all cancers, and to exchange ideas about how to improve outcomes for cancer patients. Putting patients at the center of cancer care and research is this year’s theme at ASCO, something we at The Leukemia & Lymphoma Society (LLS) try to do every day. Sprin...

    Read More
  5. Staying One Step Ahead of Myeloma – and Counting on New Research

    Myeloma is a beast. It is a complicated cancer with no cure and, with so many different types, no two patients are the same. Drugs can put it into remission, but it almost always comes back. And when it does, it’s a little more aggressive and needs to be attacked in a different way. This is knowledge I’ve been living with for four years now and I’m doing everything I can to stay one step ahead of my disease. Believing there was a cure down the line, I opted for a clinical tri...

    Read More
  6. Finding New Approaches to Immunotherapy

    Helen Heslop, M.D., leads a team of scientists being funded through LLS’s Specialized Center of Research Program (SCOR). The project brings together researchers from different institutions to test a half dozen novel approaches to cancer immunotherapy – all of which harness the patient's own immune system to fight the cancer. Heslop, a professor in the Department of Medicine and Pediatrics at Baylor College of Medicine and the director of the Center for Cell and Gene Therapy, pioneered...

    Read More
  7. Oral Therapies in Myeloma: Medication Adherence

    Learn about the importance of taking treatments as prescribed by the doctors, tips to help patients take oral medication as prescribed, and tips and strategies for successful communication with the healthcare team.

    Read More
  8. Learning to “Live” with Myeloma

    By definition a survivor is a person who copes with difficulties in their life. In 2006, my 80-year-old father was diagnosed with multiple myeloma. Like most people, I had no idea what that meant. After doing some research, I discovered it to be a cancer of the plasma cells in the bone marrow, which can be treated but not cured. He was diabetic and had heart disease, there weren’t many treatments, so options were limited. He passed within ten months. I didn’t realize it then but he showe...

    Read More
  9. My Myeloma Story

    “What is multiple myeloma?” Those were my words after the doctor’s review of my lab results for a routine and random high blood pressure exam in November 2008. I had always been healthy, had never been in the hospital, never even broken a bone. I was in great shape: a 46-year-old high school biology teacher, head softball and volleyball coach, with a beautiful young family including two teenage daughters. I got not only cancer, but an incurable form of cancer. The diagnosis was confi...

    Read More
  10. The First Official Day of #ASH15

    Beat AML is a collaboration launched nearly three years ago by LLS and the Knight Cancer Institute at Oregon Health & Science University (OHSU), to go on the offenensive against acute myeloid leukemia (AML), a blood cancer with a poor prognosis and little change in the standard of care in 40 years. More than a dozen abstracts from the first phase of the initiative will be featured throughout the American Society of Hematology (#ASH15) Annual Meeting in Orlando over the next few days. #...

    Read More